India, May 20 -- Roivant Sciences Ltd. (ROIV) shares climbed 13.95 percent to $32.15, up $3.94 on Wednesday, after the biopharmaceutical company reported a return to profitability in the fourth quarter of fiscal 2026, driven by a large litigation settlement gain.
The stock is currently trading at $32.15, compared with a previous close of $28.21 on the Nasdaq. It opened at $29.60 and traded between $29.35 and $32.25 during the session, with volume reaching 4.50 million shares, slightly below the average daily volume of 5.52 million shares.
Revenue declined to $2.5 million in the quarter ended March 31, 2026, from $7.6 million in the same period last year. Net income totaled $303.0 million, or $0.28 per share, compared with a net loss of $2...